Press Release

MMJ’s FDA-First Cannabis Pharmaceutical Model Thrives Amid DEA Regulatory Gridlock

The DEA is "out of touch" and resistant to reform, stated Ben Kovler. Yet, amid this uncertainty, MMJ International Holdings has charted a distinct course-one rooted in pharmaceutical rigor-that's positioning the company as a trailblazer in the medical cannabis space.

Read More